Emerging HER2-targeted treatment approaches for gastroesophageal cancer in the era of chemo-immunotherapy

Pharmacology & Therapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles